EE200200596A - Mobiliseeriva toimega preparaat - Google Patents

Mobiliseeriva toimega preparaat

Info

Publication number: EE200200596A
Authority: EE; Estonia
Prior art keywords: preparation; mobilizing effect; haematopoietic; mobilizing; effect
Prior art date: 2000-04-18

Application number

EEP200200596A

Other languages

English (en)

Estonian (et)

Inventor

Ferro Laura

Porta Roberto

Iacobelli Massimo

Massimo Gianni Alessandro

Carlo Stella Carmelo

Original Assignee

Gentium Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2001-04-10

Publication date

2004-04-15

2001-04-10 Application filed by Gentium Spa filed Critical Gentium Spa

2004-04-15 Publication of EE200200596A publication Critical patent/EE200200596A/xx

Links

230000001483 mobilizing effect Effects 0.000 title 1
230000003394 haemopoietic effect Effects 0.000 abstract 2
210000000130 stem cell Anatomy 0.000 abstract 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 abstract 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
JNWFIPVDEINBAI-UHFFFAOYSA-N [5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(C(C)C)=CC(C=2N(C(=O)NN=2)C=2C=C3C=CN(C)C3=CC=2)=C1O JNWFIPVDEINBAI-UHFFFAOYSA-N 0.000 abstract 1
229960004120 defibrotide Drugs 0.000 abstract 1
210000005259 peripheral blood Anatomy 0.000 abstract 1
239000011886 peripheral blood Substances 0.000 abstract 1
230000002123 temporal effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EEP200200596A 2000-04-18 2001-04-10 Mobiliseeriva toimega preparaat EE200200596A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00830293A EP1147777A1 (de)	2000-04-18	2000-04-18	Kombination von Defibrotid und G-CSF und ihre Verwendung zur Aktivierung der hämatopoiestischen Vorläuferzellen
PCT/EP2001/004105 WO2001078761A2 (en)	2000-04-18	2001-04-10	Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (1)

Publication Number	Publication Date
EE200200596A true EE200200596A (et)	2004-04-15

Family

ID=8175292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200596A EE200200596A (et)	2000-04-18	2001-04-10	Mobiliseeriva toimega preparaat

Country Status (31)

Country	Link
US (1)	US20040131588A1 (de)
EP (3)	EP1147777A1 (de)
JP (1)	JP5205668B2 (de)
KR (1)	KR100849491B1 (de)
CN (1)	CN1183962C (de)
AT (2)	ATE443524T1 (de)
AU (2)	AU2001258322B2 (de)
BG (1)	BG107203A (de)
CA (1)	CA2406179C (de)
CY (1)	CY1104971T1 (de)
CZ (1)	CZ20023426A3 (de)
DE (2)	DE60140015D1 (de)
DK (2)	DK1621207T3 (de)
EE (1)	EE200200596A (de)
ES (2)	ES2252227T3 (de)
HR (1)	HRP20020835A2 (de)
HU (1)	HUP0300560A3 (de)
IL (1)	IL152328A (de)
IS (1)	IS2171B (de)
MX (1)	MXPA02010346A (de)
NO (1)	NO20024988L (de)
NZ (1)	NZ522016A (de)
PL (1)	PL358100A1 (de)
PT (1)	PT1621207E (de)
RO (1)	RO121006B1 (de)
RU (1)	RU2248216C2 (de)
SI (1)	SI21079B (de)
SK (1)	SK14892002A3 (de)
UA (1)	UA73566C2 (de)
WO (1)	WO2001078761A2 (de)
ZA (1)	ZA200208413B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8771663B2 (en)	2000-04-18	2014-07-08	Gentium Spa	Formulation having mobilising activity
PL1660115T3 (pl) *	2003-07-29	2011-11-30	Dompe Spa	Farmaceutyczna kombinacja G-CSF i PLGF użyteczna wobec komórek macierzystych krwi
WO2005017160A2 (en) *	2003-08-13	2005-02-24	Children's Hospital Medical Center	Mobilization of hematopoietic cells
US20050069553A1 (en)	2003-08-13	2005-03-31	Yi Zheng	Chimeric peptides for the regulation of GTPases
EP2103689A1 (de) *	2008-03-19	2009-09-23	Gentium S.p.A.	Synthetische Phosphodiester-Oligonukleotide und deren therapeutische Verwendungen
RU2376985C1 (ru) *	2008-07-17	2009-12-27	Владислав Николаевич Ласкавый	Средство для активации стволовых клеток
ES2694239T3 (es)	2010-11-12	2018-12-19	Gentium S.R.L.	Defibrótido para su uso en profilaxis y/o tratamiento de la enfermedad de Injerto contra huésped (GVHD)
RU2627177C2 (ru)	2012-06-22	2017-08-03	Джентиум С.Р.Л.	Способ определения биологической активности дефибротида, основанный на применении эуглобулина
EP3026122A1 (de)	2014-11-27	2016-06-01	Gentium S.p.A.	Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid
CN106567694A (zh) *	2016-11-14	2017-04-19	北京国泰通源技术有限公司	智能控水短节
RU2758487C2 (ru) *	2018-01-12	2021-10-28	Селлмиг Биолабс Инк.	Способы получения цитокапсул и цитокапсулярных трубок
CN114730031B (zh)	2019-11-13	2024-04-12	富士胶片株式会社	装饰膜、成型物及电子器件
CN117072108A (zh) *	2023-06-28	2023-11-17	中国石油天然气集团有限公司	一种旋转防喷控压一体化装置、密封方法及控压方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899481A (en)	1970-11-03	1975-08-12	Crinos Industria Farmaco	Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de)	1970-11-03	1972-05-25	Crinos Industria Farmaco	Medikamente für das fibrinolytische System
IT1043823B (it) *	1970-11-03	1980-02-29	Prephar	Procedimento per l estrazione di acidi nucleici da organi animali
IT1206341B (it)	1984-02-16	1989-04-14	Crinos Industria Farmaco	Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en)	1985-05-28	1987-09-15	Ajax Magnethermic Corporation	Apparatus for overheating edges of skelp for the production of compression welded pipe
IT1190313B (it)	1986-04-17	1988-02-16	Crinos Industria Farmaco	Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en)	1986-04-17	1993-06-29	Crinos Industria Farmacobiologica S.P.A.	Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1223322B (it) *	1987-10-23	1990-09-19	Crinos Industria Farmaco	Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) *	1988-08-24	1999-06-21	中外製薬株式会社	抗血栓剤
IT1231509B (it) *	1989-09-07	1991-12-07	Crinos Industria Farmaco	Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) *	1991-06-07	1993-04-06	Immunex Corporation	Method for improving autologous transplantation
US5977083A (en) *	1991-08-21	1999-11-02	Burcoglu; Arsinur	Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) *	1992-01-28	2000-03-15	松下電器産業株式会社	電動調理機
RU2136667C1 (ru) *	1995-04-18	1999-09-10	Научно-исследовательский институт фармакологии РАМН	Производные 2-меркаптобензимидазола, обладающие противоишемической, антиаритмической и противофибрилляторной активностью
JPH08127539A (ja) *	1994-10-31	1996-05-21	Ajinomoto Co Inc	ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
US5856444A (en) *	1994-11-30	1999-01-05	Chugai Seiyaku Kabushiki Kaisha	Thrombocytopoiesis stimulating factor
EP0937461B1 (de) *	1996-07-10	2005-07-06	Meiji Dairies Corporation	Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
AU1705599A (en) *	1997-11-26	1999-06-15	Allegheny University Of The Health Sciences	Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) *	1999-01-07	2003-06-03	Heska Corporation	Feline immunoglobulin E molecules and compositions there of

2000
- 2000-04-18 EP EP00830293A patent/EP1147777A1/de not_active Withdrawn
2001
- 2001-04-10 PT PT05108424T patent/PT1621207E/pt unknown
- 2001-04-10 AU AU2001258322A patent/AU2001258322B2/en not_active Ceased
- 2001-04-10 AU AU5832201A patent/AU5832201A/xx active Pending
- 2001-04-10 PL PL01358100A patent/PL358100A1/xx not_active Application Discontinuation
- 2001-04-10 AT AT05108424T patent/ATE443524T1/de active
- 2001-04-10 WO PCT/EP2001/004105 patent/WO2001078761A2/en not_active Ceased
- 2001-04-10 RU RU2002130719/15A patent/RU2248216C2/ru not_active IP Right Cessation
- 2001-04-10 SI SI200120022A patent/SI21079B/sl not_active IP Right Cessation
- 2001-04-10 DK DK05108424.2T patent/DK1621207T3/da active
- 2001-04-10 CZ CZ20023426A patent/CZ20023426A3/cs unknown
- 2001-04-10 JP JP2001576061A patent/JP5205668B2/ja not_active Expired - Fee Related
- 2001-04-10 EP EP01931582A patent/EP1276497B1/de not_active Expired - Lifetime
- 2001-04-10 EE EEP200200596A patent/EE200200596A/xx unknown
- 2001-04-10 RO ROA200201305A patent/RO121006B1/ro unknown
- 2001-04-10 KR KR1020027013967A patent/KR100849491B1/ko not_active Expired - Fee Related
- 2001-04-10 DK DK01931582T patent/DK1276497T3/da active
- 2001-04-10 US US10/432,741 patent/US20040131588A1/en not_active Abandoned
- 2001-04-10 IL IL152328A patent/IL152328A/en active IP Right Grant
- 2001-04-10 SK SK1489-2002A patent/SK14892002A3/sk unknown
- 2001-04-10 EP EP05108424A patent/EP1621207B1/de not_active Expired - Lifetime
- 2001-04-10 NZ NZ522016A patent/NZ522016A/en unknown
- 2001-04-10 CA CA2406179A patent/CA2406179C/en not_active Expired - Fee Related
- 2001-04-10 DE DE60140015T patent/DE60140015D1/de not_active Expired - Lifetime
- 2001-04-10 AT AT01931582T patent/ATE310532T1/de active
- 2001-04-10 CN CNB018082025A patent/CN1183962C/zh not_active Expired - Fee Related
- 2001-04-10 HU HU0300560A patent/HUP0300560A3/hu unknown
- 2001-04-10 MX MXPA02010346A patent/MXPA02010346A/es active IP Right Grant
- 2001-04-10 ES ES01931582T patent/ES2252227T3/es not_active Expired - Lifetime
- 2001-04-10 ES ES05108424T patent/ES2335776T3/es not_active Expired - Lifetime
- 2001-04-10 HR HR20020835A patent/HRP20020835A2/xx not_active Application Discontinuation
- 2001-04-10 DE DE60115222T patent/DE60115222T2/de not_active Expired - Lifetime
- 2001-10-04 UA UA2002119177A patent/UA73566C2/uk unknown
2002
- 2002-10-14 IS IS6581A patent/IS2171B/is unknown
- 2002-10-16 NO NO20024988A patent/NO20024988L/no not_active Application Discontinuation
- 2002-10-17 BG BG107203A patent/BG107203A/bg unknown
- 2002-10-17 ZA ZA200208413A patent/ZA200208413B/en unknown
2006
- 2006-02-08 CY CY20061100179T patent/CY1104971T1/el unknown

Also Published As

Publication number	Publication date
CA2406179A1 (en)	2001-10-25
NZ522016A (en)	2004-10-29
JP2004500437A (ja)	2004-01-08
SK14892002A3 (sk)	2003-06-03
EP1276497B1 (de)	2005-11-23
IS2171B (is)	2006-11-15
EP1147777A1 (de)	2001-10-24
EP1621207B1 (de)	2009-09-23
AU2001258322B2 (en)	2006-03-16
IS6581A (is)	2002-10-14
NO20024988L (no)	2002-12-02
EP1621207A2 (de)	2006-02-01
MXPA02010346A (es)	2004-09-06
DK1621207T3 (da)	2010-02-01
HUP0300560A2 (hu)	2003-06-28
KR100849491B1 (ko)	2008-07-31
PT1621207E (pt)	2009-12-28
SI21079B (sl)	2006-08-31
UA73566C2 (en)	2005-08-15
IL152328A (en)	2009-12-24
WO2001078761A2 (en)	2001-10-25
EP1621207A3 (de)	2006-11-22
RO121006B1 (ro)	2006-11-30
CY1104971T1 (el)	2010-03-03
CN1183962C (zh)	2005-01-12
DE60115222T2 (de)	2006-08-10
SI21079A (sl)	2003-06-30
HUP0300560A3 (en)	2005-07-28
NO20024988D0 (no)	2002-10-16
CZ20023426A3 (cs)	2003-05-14
WO2001078761A3 (en)	2002-01-24
ES2252227T3 (es)	2006-05-16
RU2248216C2 (ru)	2005-03-20
ATE310532T1 (de)	2005-12-15
HRP20020835A2 (en)	2005-10-31
PL358100A1 (en)	2004-08-09
ZA200208413B (en)	2003-10-17
US20040131588A1 (en)	2004-07-08
ATE443524T1 (de)	2009-10-15
AU5832201A (en)	2001-10-30
JP5205668B2 (ja)	2013-06-05
DE60115222D1 (de)	2005-12-29
ES2335776T3 (es)	2010-04-05
CA2406179C (en)	2012-03-27
DK1276497T3 (da)	2006-03-27
KR20030010603A (ko)	2003-02-05
EP1276497A2 (de)	2003-01-22
IL152328A0 (en)	2003-05-29
CN1434719A (zh)	2003-08-06
DE60140015D1 (de)	2009-11-05
BG107203A (bg)	2003-05-30
RU2002130719A (ru)	2004-03-27

Publication	Publication Date	Title
EE200200596A (et)	2004-04-15	Mobiliseeriva toimega preparaat
AU2001269688A1 (en)	2002-01-14	Combination containing an antifolate and methylmalonic acid lowering agent
ES2160577T3 (es)	2001-11-16	Nuevos esteres de aminoalcoholes biciclicos y triciclicos, su preparacion y su utilizacion en medicamentos.
IL138979A0 (en)	2001-11-25	Use of cannabinoids as anti-inflammatory agents
DK1244408T3 (da)	2005-07-11	Absorberende artikel, hvor hovedabsorptionsdelen er i den forreste del
ES2192839T3 (es)	2003-10-16	Timosina beta 4 oxidada.
NZ516349A (en)	2004-03-26	Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
IL158155A0 (en)	2004-03-28	Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
AU2001261986A1 (en)	2001-12-03	Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
ITMI992107A0 (it)	1999-10-08	Uso del baclofen nel trattamento dell'astinenza da etanolo
AU2002332488A8 (en)	2004-02-25	R-bambuterol, its preparation and therapeutic uses
EP1023901A4 (de)	2004-10-27	Heilmittel für hepatitis c und dessen verwendung
YU79802A (sh)	2005-11-28	Formulacija sa aktivnošću mobilizacije
ES2181915T3 (es)	2003-03-01	Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
EP1123100A4 (de)	2001-12-19	Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta-estern desselben
FI851365A0 (fi)	1985-04-04	Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DK0458537T3 (da)	1999-10-18	Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
JPS6461429A (en)	1989-03-08	Remedy for cancer
Levant et al.	2000	" The evolving profession of psychology: Comment on Lowe Hays-Thomas's (2000)'The silent conversation'": Correction to Levant et al.(2000).
ECSP003380A (es)	2000-07-21	Derivados de campotecina con actividad antitumoral
IT247575Y1 (it)	2002-09-09	Perfezionamenti alle siringhe per la esecuzione della anestesiaepidurale.